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objective. Targeted surveillance has focused on device-associated infections and surgical site infections (SSIs) and is often limited to
healthcare-associated infections (HAIs) in high-risk areas. Longitudinal trends in all HAIs, including other types of HAIs, and HAIs outside of
intensive care units (ICUs) remain unclear. We examined the incidences of all HAIs using comprehensive hospital-wide surveillance over a
12-year period (2001–2012).
methods. This retrospective observational study was conducted at the University of North Carolina (UNC) Hospitals, a tertiary care
academic facility. All HAIs, including 5 major infections with 14 specific infection sites as defined using CDC criteria, were ascertained through
comprehensive hospital-wide surveillance. Generalized linear models were used to examine the incidence rate difference by infection type
over time.
results. A total of 16,579 HAIs included 6,397 cases in ICUs and 10,182 cases outside ICUs. The incidence of overall HAIs decreased
significantly hospital-wide (−3.4 infections per 1,000 patient days), in ICUs (−8.4 infections per 1,000 patient days), and in non-ICU settings
(−1.9 infections per 1,000 patient days). The incidences of bloodstream infection, urinary tract infection, and pneumonia in hospital-wide
settings decreased significantly, but the incidences of SSI and lower respiratory tract infection remained unchanged. The incidence of
Clostridium difficile infection (CDI) increased remarkably. The outcomes were estimated to include 700 overall HAIs prevented, 40 lives saved,
and cost savings in excess of $10 million.
conclusions. We demonstrated success in reducing overall HAIs over a 12-year period. Our data underscore the necessity for surveillance
and infection prevention interventions outside of the ICUs, for non–device-associated HAIs, and for CDI.
Infect. Control Hosp. Epidemiol. 2015;36(10) :1139–1147
In the late 1990s, decreasing resources led many hospitals to
shift from hospital-wide to targeted surveillance, which was
codified in the 1998 National Nosocomial Infections Surveil-
lance (NNIS) surveillance definitions.1,2 Targeted surveillance
focuses on specific healthcare-associated infections (HAIs)
(eg, device-associated infections, surgical-site infections [SSIs],
and laboratory-based infections due to Clostridium difficile and
methicillin-resistant Staphylococcus aureus) and high-risk areas
(eg, intensive care units, [ICUs]) within the hospital. Infection
prevention and control efforts have greatly reduced the inci-
dence of HAIs, especially device–associated infections such
as central-line–associated bloodstream infection (CLABSI),
ventilator-associated pneumonia (VAP), and catheter-associated
urinary tract infection (CAUTI).3–5 However, longitudinal trends
among all HAIs, including non–device-associated HAIs, other
types of HAI, and HAIs outside of ICUs, remain unknown since
many hospitals do not implement comprehensive hospital-wide
surveillance.
At the University of North Carolina (UNC) Hospitals, we
have conducted comprehensive hospital-wide surveillance for
all HAIs in accordance with the Centers for Disease Control and
Prevention (CDC) criteria since 1978. In this study, we
investigated the trends and incidences of all HAIs, including
bloodstream infection (BSI), urinary tract infection (UTI),
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respiratory tract infection (RTI), SSI, and other types of HAI.
Furthermore, we assessed outcomes (ie, HAIs prevented, lives
saved, and cost savings) as a result of our infection control
activities over the last decade.
methods
This study was conducted at UNC Hospitals, an 806-bed
tertiary care academic facility using the Hospital Epidemiology
HAI data for 12 years from 2001 to 2012. Comprehensive
hospital-wide surveillance for all HAIs that included all CDC-
defined sites was performed through a chart review of each
patient in accordance with CDC criteria as recommended
that year6 by 5 infection preventionists and 3 full-time faculty
members. Sources for HAI identification included laboratory
reports of positive culture results, results of serological testing
or molecular-based diagnostic tests, morbidity and mortality
conferences, autopsies, and reports of infections from clinics
and physicians. For analyses by unit category within UNC
Hospitals, all HAIs and units were classified as ICUs or non-
ICUs. Step-down units were classified as non-ICUs because
those units had infection rates more similar to those of gen-
eral wards than those of the ICUs.7 According to CDC cri-
teria, all HAIs were categorized as 1 of the following 5 major
infections with 14 specific infection sites: BSIs, UTIs, RTIs
(pneumonia; lower respiratory tract infections [LRTIs]), SSIs,
and other types of HAI (gastrointestinal infections; eye,
ear, nose, throat, or mouth infections; skin and soft-tissue
infections; cardiovascular system infections; bone and joint
infections; central nervous system infections; reproductive
tract infections; systemic infections).6 All surveillance data
regarding HAIs during the study period were entered into an
electronic database.
Relative proportions were calculated as each infection site
versus all HAIs per year that were available from 2001 to 2012.
Incidences of device-associated infection (CLABSI, VAP, and
CAUTI) were calculated as infections per 1,000 device days
and SSI incidence was calculated as infections per 100 proce-
dures. Incidences of HAIs other than these device-associated
infections and SSI were calculated as the number of HAIs per
1,000 patient days. Denominator data were collected according
to CDC criteria8 and were classified into the same infection site
and unit category as the numerator data. Denominators for the
incidences were available in the following areas and periods
(the first year listed was considered the baseline year): patient
days at overall hospitals, ICUs, and non-ICUs in 2003–2012;
central-line days at ICUs in 2003–2012 and at overall hospitals
and non-ICUs in 2007–2012; ventilator days at ICUs in
2004–2012; catheter days at overall hospitals, ICUs, and
non-ICUs in 2006–2012; and procedures at overall hospitals in
2005–2012 (Table 1).
We estimated the annual number of HAIs prevented
through our infection control activities in each year by
calculating the risk reduction from the difference in incidences
between the given year and the last year, and then we calcu-
lated the average annual number of HAIs prevented and the
total number of HAIs prevented over the last decade. We also
estimated the number of lives saved by multiplying the
estimated number of infections prevented by the case fatality
rates of specific HAIs and overall,1,9 and we calculated the cost
savings using low and high cost estimates as previously
described (Online Table S1).5,10
SAS® version 9.3 (SAS Institute Inc., Cary, NC, USA) was used
for statistical analysis. Generalized linear models were used to
examine the incidence rate difference by infection type over
time. Statistical significance was calculated by comparing these
regression lines to a line with a zero slope. P< .05 was considered
table 1. A List of Denominator Data Used to Calculate Incidences of Healthcare-Associated Infections (HAIs) in this Study
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Overall hospitals
Patient days 200,914 207,783 207,570 216,716 227,623 211,889 234,054 234,637 244,131 248,974
No. of procedures (SSI)a 20,161 21,510 23,449 25,311 25,929 28,616 31,250 31,501
Central-line days (CLABSI) 80,869 78,469 80,838 84,025 87,448 88,134
Catheter days (CAUTI) 62,147 63,050 62,387 61,327 60,357 58,981 57,740
Intensive care units
Patient days 41,341 42,122 42,807 47,309 41,171 38,286 41,964 41,747 51,146 45,422
Central-line days (CLABSI) 25,150 26,901 28,780 30,751 29,318 27,333 29,570 28,190 29,048 28,315
Catheter days (CAUTI) 27,537 27,993 27,162 26,221 26,011 25,911 25,150
Ventilator days (VAP) 16,591 18,681 21,007 19,822 17,765 18,721 17,779 19,855 18,887
Outside of intensive care units
Patient days 159,573 165,661 164,763 169,407 186,452 173,603 192,090 192,890 192,985 203,552
Central-line days (CLABSI) 51,551 51,136 51,268 55,835 58,400 59,819
Catheter days (CAUTI) 34,610 35,057 35,225 35,106 34,346 33,070 32,590
aThroughout, the parentheses indicate denominators used to calculate incidences of specific HAI.
NOTE. SSI, surgical site infection; CLABSI, central line-associated bloodstream infection; CAUTI, catheter-associated urinary tract infection;
VAP, ventilator-associated pneumonia.
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statistically significant. This study was approved by the Institu-
tional Review Board of UNC Chapel Hill (IRB No. 06-0437).
results
Of a total of 16,579 HAIs that occurred during the 12-year
study period, 6,397 HAIs occurred in ICUs (33%–44% of all
HAIs each year) and 10,182 HAIs occurred in non-ICU
settings (56%–67% of all HAIs each year) (Figure 1). The
incidence of overall HAIs throughout UNC Hospitals
decreased significantly from 7.90 in 2003 to 4.60 in 2012
infections per 1,000 patient days (ie, 42% reduction, incidence
rate difference=−3.39, P< .001).
Relative proportion of HAIs by major infection site and
incidences of HAIs by specific infection site in overall UNC
Hospitals are provided in Figure 2 and Table 2. Overall at UNC
Hospitals, the relative proportions of BSI and UTI decreased by
13% and 5%, and the incidence of RTI remained unchanged,
but the incidences of SSI and C. difficile infection (CDI)
increased by 9% and 16%, respectively. The relative proportion
of other types of HAI approximately doubled throughout UNC
Hospitals from 2001 to 2012. Overall at UNC Hospitals, the
incidence rate difference for BSI was −1.53 infections per 1,000
patient days (P< .001); for pneumonia the incidence rate dif-
ference was −0.50 infections per 1,000 patient days (P< .001);
and for UTI the incidence rate difference was −1.55 infections
per 1,000 patient days (P< .001). However, the incidence rates
of LRTI, SSI, and other types of HAI remained unchanged. In
other types of HAI, the incidence rate differences for cardio-
vascular system infections, gastrointestinal infections, and skin
and soft-tissue infections were −0.19 (P< .001), +0.53
(P= .003), and −0.20 (P< .001) per 1,000 patient days,
respectively. The incidences of bone and joint infection, eye,
ear, nose, throat, or mouth infections, central nervous system
infection, reproductive tract infection, and systemic infection in
overall UNC Hospitals were <0.1 infections per 1,000 patient
days. The incidence rate differences for CLABSI, VAP, and
CAUTI were −1.39 (P= .001) infections per 1,000 central-line
days, −4.52 (P< .001) infections per 1,000 ventilator days, and
−3.20 (P= .005) infections per 1,000 catheter days, respectively.
Thus, there was a striking reduction in such device-associated
infections. Importantly, the incidence of CDI increased sig-
nificantly from 0.11 in 2003 to 0.81 in 2012 per 1,000 patient
days throughout UNCHospitals (ie, a 636% increase, incidence
figure 1. Relative proportion (A) and incidences (B) of all healthcare-associated infections (HAIs) in intensive care units (ICUs) and
outside of ICUs at University of North Carolina (UNC) Hospitals, 2001–2012. In ICU settings, HAI incidence fell from 16.84 to 8.37
infections per 1,000 patient days (50% reduction, incidence rate difference=−8.39, P< .001). In non-ICU settings, the HAI incidence fell
from 5.58 to 3.75 infections per 1,000 patient days (33% reduction, incidence rate difference=−1.92, P< .001).
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rate difference=+0.66, P< .001), and this rate surged notably
from 2010 despite no change in surveillance criteria and
detection methods for CDI.
Figure 3 shows the relative proportion of HAIs by major
infection site and incidences of HAIs by specific infection site in
ICUs. In the ICU settings, the relative proportion of BSI
decreased by 9%, and RTI, UTI, and SSI rates remained
unchanged, but the CDI rate increased by 14%. The relative
proportion of HAIs by major infection site and incidences of
HAIs by specific infection site outside of the ICUs are shown in
Figure 4. In non-ICU settings, the relative proportions of BSI and
UTI decreased by 16% and 8%, and RTI rates remained
unchanged, but SSI and CDI rates increased by 12% and 17%,
respectively.
The estimated number of HAIs prevented, lives saved, cost
savings at UNC Hospitals over the last decade are summarized
in Table 3. We estimate that the surveillance and infection
control measures implemented at UNC Hospitals prevented
714 overall HAIs, 285 BSIs, 126 RTIs, 297 UTIs, and 85 SSIs.
We estimate that over the last decade, 41 overall HAI deaths
were prevented, as well as 35 deaths from BSI, 18 from
RTI, 7 from UTI, and 2 from SSI. In total, UNC Hospitals
saved $1.6–$2.1 million per year, with cumulative savings of
$14.7–$18.5 million over the last decade. In contrast, UNC
Hospitals recorded more than 189 other HAIs associated with
CDI during the study period, with an estimated cost of
$1.2–$1.7 million.
discussion
A recent, large prevalence study by Magill et al11 reported that
the most common types of HAI were SSI, pneumonia, and
gastrointestinal infection (principally CDI). Other data from
the same year, 2011, were similar, with high prevalences of SSI,
RTI, and CDI. However, our study, which assessed incidence
rates of HAIs over time, extends the finding of Magill et al by
demonstrating success in reducing overall HAI rates
throughout the UNC Hospital system over the last decade,
especially in ICU settings, and we have provided further evi-
dence of the necessity for infection prevention efforts in non-
ICU inpatient units.
Many hospitals have shifted to targeted surveillance (eg, in the
ICUs or for specific HAIs such as CLABSI, VAP, CAUTI, and
figure 2. Relative proportion (A) and incidences (B) of healthcare-associated infections (HAIs) by major infection site overall in
University of North Carolina (UNC) Hospitals, 2001–2012. BSI, bloodstream infection; RTI, respiratory tract infection; UTI, urinary tract
infection; SSI, surgical site infection; CDI, Clostridium difficile infection. Incidence of SSI was calculated as infections per 100 procedures.
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SSI), but recent data on hospital-wide HAIs, including
non-ICU patients, are scarce. Hospital-wide HAIs may be
underestimated by targeted surveillance because such surveil-
lance detects HAIs only in high-risk areas (eg, ICUs), on specific
units, associated with certain services, or at specific infection sites
(eg, device-associated HAIs). Our previous study showed that
targeted surveillance missed approximately 50% of HAIs that are
not included in published NHSN reports, compared with com-
prehensive hospital-wide surveillance (ie, all hospital units, all
HAIs).12 Other studies that focused only on CLABSI have
described the burden of these infections outside the ICUs.13–15
As a result of comprehensive hospital-wide surveillance and
infection control measures over the last decade, the outcomes
at UNC Hospitals during the study period were estimated as
700 overall HAIs prevented, 40 lives saved, and cost savings of
more than $10 million. Our hospital-wide surveillance was
conducted by 2.4 professional full-time equivalents (FTEs) and
5 infection preventionist FTEs in the UNC Hospital system
(860 beds: 171 ICU beds and 689 non-ICU beds). Staff chan-
ged occasionally. According to a survey to members of the
Society for Healthcare Epidemiology of America,16 the median
numbers of physician FTEs and infection control practitioner
FTEs in facilities larger than 600 beds were 1.00 (range, 0–10)
and 3.9 (range, 0.13–6.1), respectively. Staff allocation to
implement surveillance in our hospital was likely to be
affordable and within the range of the survey results. Although
there was concern regarding the incremental workload cost of
HAI surveillance, our labor costs corresponded to less than
half the annual cost saved based on physician earnings
($151,000–$200,000) and infection preventionist earnings
($69,339–$99,024) by region.16,17
The frequencies of other types of HAI due to CDI and non-
CDI doubled in 2012. We previously described “other” types of
HAI and pathogens causing such infections.18 This study pro-
vides further details regarding incidences of 8 specific “other”
types of HAI in both ICU and non-ICU settings at UNC Hos-
pitals over the last decade. For CDI, an additional 20 other HAI
types were associated with costs of more than $100,000 per year.
Gastrointestinal infections are now increasing, and C. difficile
was our most common healthcare-associated pathogen at UNC
table 2. Overall Incidences of Healthcare-Associated Infections (HAIs) by Specific Infection Site in UNC Hospitals, 2003–2012
Incidencea
Incidence Rate
Infection Type 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Difference P Value
BSI 2.07 2.00 1.67 1.37 1.12 1.06 0.84 0.84 0.61 0.67 −1.53 <.001
CLABSI … … … … 2.63 2.31 2.07 1.82 1.26 1.37 −1.39 .001
Non-CLABSI 0.37 0.30 0.35 0.20 0.19 0.21 0.12 0.19 0.16 0.18 −0.2 .004
RTI 1.32 1.28 1.25 1.02 0.82 1.15 1.00 0.94 0.95 0.74 −0.48 .004
Pneumonia 0.84 0.81 0.82 0.65 0.53 0.66 0.53 0.45 0.40 0.38 −0.5 <.001
VAP … 6.57 5.78 4.09 3.63 4.67 3.04 2.31 2.22 1.80 −4.52 <.001
Non-VAP 0.36 0.41 0.30 0.25 0.22 0.27 0.29 0.28 0.22 0.25 −0.12 .028
LRTI 0.46 0.45 0.42 0.33 0.27 0.46 0.43 0.48 0.49 0.33 −0.005 .929
UTI 2.30 2.23 2.37 1.99 2.17 1.54 1.11 1.30 1.13 0.96 −1.55 <.001
CAUTI … … … 5.02 5.71 3.86 2.98 3.15 2.58 2.36 −3.2 .005
Non-CAUTI … … … 0.55 0.59 0.41 0.32 0.49 0.51 0.42 −0.1 .379
SSI … … 1.23 1.25 1.22 1.31 1.39 1.17 0.99 0.94 −0.28 .078
Other CDI 0.11 0.11 0.31 0.32 0.37 0.32 0.28 0.55 0.79 0.81 0.66 <.001
Other non-CDI 0.83 0.80 0.54 0.61 0.45 0.35 0.34 0.33 0.29 0.23 −0.6 <.001
BJ 0 0 0.01 0 0 0.01 0 0 0.01 0 −0.003 .53
CVS 0.20 0.20 0.12 0.12 0.05 0.09 0.07 0.05 0.01 0.01 −0.19 <.001
EENT 0.05 0.05 0.03 0.06 0.04 0.02 0.04 0.03 0.04 0.02 −0.02 .059
GI 0.28 0.27 0.41 0.42 0.47 0.37 0.33 0.60 0.83 0.85 0.53 .003
CNS 0.05 0.05 0.02 0.02 0.04 0.03 0.01 0.01 0.01 0.02 −0.03 .018
REPR 0 0 0.01 0 0 0 0.03 0.01 0.02 0.01 0.02 .155
SST 0.32 0.31 0.24 0.31 0.19 0.14 0.13 0.18 0.16 0.13 −0.2 <.001
SYS 0.02 0.02 0 0.01 0.01 0 0.01 0 0 0 −0.02 .016
All HAIs 7.90 7.64 7.33 6.55 6.19 5.99 5.11 5.40 5.05 4.59 −3.39 <.001
NOTE. BSI, bloodstream infection; CLABSI, central-line–associated bloodstream infection; RTI, respiratory tract infection; Pneumonia, pneu-
monia; VAP, ventilator-associated pneumonia; LRTI, lower respiratory tract infection; UTI, urinary tract infection; CAUTI, catheter-associated
urinary tract infection; SSI, surgical site infection; CDI, Clostridium difficile infection, BJ, bone and joint infection; CVS, cardiovascular system
infection; EENT, eye, ear, nose, throat, or mouth infection; GI, gastrointestinal infection; CNS, central nervous system infection; REPR,
reproductive tract infection; SST, skin and soft-tissue infection; SYS, systemic infection.
aIncidences of device-associated infections (CLABSI, VAP, and CAUTI) and SSI were calculated as infections per 1,000 device days and
infections per 100 procedures, respectively. Incidences of HAI except those device-associated infections and SSI were calculated as the number of
infections per 1,000 patient days. The data (…) were not available.
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Hospitals in this study (2001–2012) and our previous study.19 A
recent national prevalence survey described the importance of
surveillance of other HAIs, including gastrointestinal infections
due to C. difficile (12.1%) in the United States in 2011.11 At our
hospital, the incidences of cardiovascular system infections and
skin and soft-tissue infections were significantly reduced, but
because of the very low number of infections, the following
incidences were not evaluated: bone and joint infections; eye,
figure 3. Relative proportion (A) and incidences (B) of healthcare-associated infections (HAIs) by major infection site in intensive care
units (ICUs), 2001–2012. The incidence rate differences for BSI, pneumonia, and UTI were −3.57 (P< .001), −1.96 (P< .001), and −1.75
(P= .006) infections per 1,000 patient days, respectively, but the incidence rate for lower respiratory tract infection remained unchanged. In
other types of HAI, the incidence rate differences for cardiovascular system infection; eye, ear, nose, throat, or mouth infection;
gastrointestinal infection; central nervous system infection; and skin and soft-tissue infection were −0.66 (P< .001), −0.05 (P= .45), +0.51
(P= .05), −0.13 (P= .07), and −0.69 (P< .001), respectively. The incidence the categories of bone and joint infection, reproductive tract
infection, or systemic infection in the ICU settings each was <0.1 infections per 1,000 patient days. BSI, bloodstream infection; RTI,
respiratory tract infection; UTI, urinary tract infection; SSI, surgical site infection; CDI, Clostridium difficile infection.
table 3. The Estimated Number of Healthcare-Associated Infections (HAIs) Prevented, Lives Saved, and Cost Savings at University of






















BSI 31.7 285.0 3.9 35.1 230,758 923,160 2,076,824 8,308,438
RTI 14.0 126.3 2.0 18.2 275,573 400,145 2,480,158 3,601,301
UTI 33.0 297.0 0.8 6.9 28,448 33,233 256,028 299,096
SSI 9.5 85.3 0.3 2.4 112,600 328,771 1,013,396 2,958,940
CDI −20.9 −188.5 −0.6 −5.4 −134,226 −191,117 −1,208,034 −1,720,053
All HAIs 79.4 714.2 4.5 40.7 1,630,607 2,055,459 14,675,467 18,499,131
NOTE. BSI, bloodstream infection; RTI, respiratory tract infection; UTI, urinary tract infection; SSI, surgical site infection; CDI, Clostridium
difficile infection.
aThe estimates were calculated using data from Online Table S1.
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ear, nose, throat, or mouth infections; central nervous system
infections; reproductive tract infections; and systemic infec-
tions. Our data regarding HAI incidence over the last decade
underscore the fact that “other” HAIs constitute a substantial
burden that requires further strategies for infection prevention
and control, especially for CDIs. In addition to rigorous contact
precautions and improved environmental cleaning/disinfec-
tion, new technologies, such as “no-touch” methods for room
disinfection (eg, hydrogen peroxide, ultraviolet light), are pro-
mising.20 Transmission dynamics of CDI need to be further
elucidated to aid in control.21,22
In this study, incidences of BSI, UTI, and pneumonia in
hospital-wide settings decreased significantly, with dramatic
reductions in the incidences of CLABSI (48%), VAP (73%),
and CAUTI (53%), but the incidence of LRTI remained
essentially the same over the last decade. To a greater or lesser
extent, the trend was similar to that in ICU or non-ICU set-
tings. Notably, CDC surveillance definitions have changed
somewhat over time; these changes may have impacted on
our incidence rates, although the direction and degree of
impact is unclear (ie, whether the changes would lead to an
increase or decrease in reported rates). We believe that these
changes had only a minor effect on the dramatic decreases in
HAI incidence.
Although current infection prevention strategies and
control measures do not prevent all HAIs, Umscheid et al9
estimated that 65%–70% of CLABSI and CAUTI cases and
55% of VAP and SSI cases are preventable. Multiple inter-
vention strategies have been implemented at UNCHospitals to
reduce CLABSIs, and a sustained reduction of CLABSI inci-
dence in ICU was demonstrated during 1999–2008.23 Such
intervention strategies have been expanded to a hospital-wide
program, which may result in a reduction of CLABSI incidence
throughout the hospital, including outside the ICUs, as our
data have shown. In addition to successful intervention stra-
tegies for CLABSI, we have conducted bundles of best practices
and practice recommendations for CAUTI, VAP, and SSI.24,25
Although prevention of SSI remains challenging in our
figure 4. Relative proportion (A) and incidences (B) of healthcare-associated infections (HAIs) by major infection site outside of
intensive care units (ICUs), 2001–2012. The incidence differences for BSI, pneumonia, and UTI, were −0.79 (P< .001), −0.13 (P= .006),
and −1.41 (P< .001) infections per 1,000 patient days, respectively, but lower respiratory tract infection remained unchanged. In other types
of HAI, the incidence rate differences for gastrointestinal infection and skin and soft-tissue infection were +0.50 (P= .002) and −0.13
(P= .03), respectively. Respective incidences of bone and joint infection; cardiovascular system infection; eye, ear, nose, throat, or mouth
infection; central nervous system infection; reproductive tract infection; and systemic infection in non-ICU settings were <0.1 infections per
1,000 patient days. BSI, bloodstream infection; RTI, respiratory tract infection; UTI, urinary tract infection; SSI, surgical site infection; CDI,
Clostridium difficile infection.
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hospital, rigorous and continuous bundled approaches of
prevention strategies allow significant reduction of device-
associated infections, which ultimately led to a reduction in
overall HAIs over the last decade. Detailed descriptions of
intervention strategies to control HAIs, including improved
compliance with hand hygiene, new devices (eg, chlorhexidine
patch for central IV sites), and new methods of terminal room
disinfection (eg, UV light), are beyond the scope of this study.
Several studies have described the decreasing trend of the
device-associated infections,3–5,26 and currently, device-
associated infections account for only 26% of HAIs in the
United States.11 Importantly, the incidence of non-device
infections, which are not currently assessed by NHSN, is not
changing.26 Furthermore, our study showed that the incidence
of SSI in hospital-wide settings remained unchanged (24%
reduction only), and most SSIs occurred in non-ICU units
after surgical procedures. Our data on SSI may not have
included all SSIs after discharge and in outpatient clinics
because follow-up of SSI is difficult, and no standard validated
surveillance method exists. A survey in Washington State
reported that 95% of acute care hospitals conducted
post-discharge SSI surveillance by various methods without
consistency among hospitals.27 In the United States, the most
common types of HAI were SSI (21.8%) and pneumonia.11
Owens et al28 reported that 90% of visits for SSIs after ambu-
latory surgery procedures involved treatment in the inpatient
setting. Therefore, our data regarding HAI incidence over the
last decade also highlight the importance of healthcare epide-
miology and infection control for SSIs and non-device-
associated infections including BSIs, RTIs, and UTIs.
In summary, we demonstrated the substantial reductions in
HAIs, lives saved, and cost savings related to comprehensive
hospital-wide HAI surveillance and infection control measures
over the last decade. Point-prevalence surveys of HAIs at
multiple centers have several limitations regarding representa-
tiveness and validation for data collection and the use of formula
of prevalence to incidence conversions.11,29 Thus, this study, even
at single tertiary care facility, has the strength of longitudinal data
regarding all HAIs through comprehensive hospital-wide sur-
veillance, including HAIs that could not be detected by targeted
surveillance. Our study also provides new insight regarding HAIs
outside ICUs as well as “other” HAIs, suggesting the necessity of
further infection prevention and control efforts.
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